Walleye Capital’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Walleye Capital's TAK Position: Q3 2026 in Review
Walleye Capital reduced its Takeda Pharmaceutical (TAK) stake by 90% in Q3 2026, selling an estimated $246K and leaving 1,581 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5584.
Walleye Capital first reported a position in TAK in Q3 2023 and has held it in 8 quarters since. The position peaked at $4.83M in Q1 2026. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Walleye Capital held 1,581 shares of Takeda Pharmaceutical worth $28.8K as of Q3 2026.
- Walleye Capital sold 13,888 Takeda Pharmaceutical shares in Q3 2026, an estimated $246K.
- Takeda Pharmaceutical made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5584 holding.
- Walleye Capital first reported a position in Takeda Pharmaceutical in Q3 2023 and has held it in 8 quarters since.
- Walleye Capital's Takeda Pharmaceutical position peaked at $4.83M in Q1 2026.
- 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.